NCC1OC(O[C@@H]2[C@H](O)[C@@H](OC3C(O)C(N)CC(N)C3OC3OC(CO)C(O)C(O)C3N)O[C@@H]2CO)C(N)C(O)C1O.O=S(=O)(O)O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?